These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33940348)

  • 21. Prognosis of small bowel adenocarcinoma in Crohn's disease compares favourably with de novo small bowel adenocarcinoma.
    Wieghard N; Mongoue-Tchokote S; Young JI; Sheppard BC; Tsikitis VL
    Colorectal Dis; 2017 May; 19(5):446-455. PubMed ID: 27659145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectives.
    Zaaimi Y; Aparicio T; Laurent-Puig P; Taieb J; Zaanan A
    Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):154-60. PubMed ID: 26547136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
    Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
    Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Single Institutional Analysis of Systemic Therapy for Unresectable or Recurrent Small Bowel Adenocarcinoma.
    Makino S; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Yamamoto H; Doki Y; Mori M; Mizushima T
    Anticancer Res; 2017 Mar; 37(3):1495-1500. PubMed ID: 28314324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?
    Dell'Aquila E; Zeppola T; Stellato M; Pantano F; Scartozzi M; Madaudo C; Pietrantonio F; Cremolini C; Aprile G; Vincenzi B; Moretto R; Puzzoni M; Garattini SK; Lobefaro R; Tonini G; Santini D
    Clin Med Insights Oncol; 2020; 14():1179554920946693. PubMed ID: 32821190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of small bowel adenocarcinoma: making the most of the available evidence to inform routine practice.
    Mazlom H; Teuwen LA; Peeters M
    Curr Opin Oncol; 2021 Jul; 33(4):368-371. PubMed ID: 33882527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine.
    Ono M; Shirao K; Takashima A; Morizane C; Okita N; Takahari D; Hirashima Y; Eguchi-Nakajima T; Kato K; Hamaguchi T; Yamada Y; Shimada Y
    Gastric Cancer; 2008; 11(4):201-5. PubMed ID: 19132481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence and Survival Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Small Bowel Adenocarcinoma.
    Saxena A; Valle SJ; Liauw W; Morris DL
    Anticancer Res; 2017 Oct; 37(10):5737-5742. PubMed ID: 28982894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
    Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
    J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study.
    Zaanan A; Gauthier M; Malka D; Locher C; Gornet JM; Thirot-Bidault A; Tougeron D; Taïeb J; Bonnetain F; Aparicio T;
    Cancer; 2011 Apr; 117(7):1422-8. PubMed ID: 21425142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
    Park HS; Jung M; Shin SJ; Heo SJ; Kim CG; Lee MG; Beom SH; Lee CY; Lee JG; Kim DJ; Ahn JB
    Ann Surg Oncol; 2016 Mar; 23(3):928-35. PubMed ID: 26514121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient with Lynch syndrome with subsequent development of small bowel adenocarcinoma.
    Azizi AH; Inam ZS; Farrell TJ
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29866690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.
    Ecker BL; McMillan MT; Datta J; Mamtani R; Giantonio BJ; Dempsey DT; Fraker DL; Drebin JA; Karakousis GC; Roses RE
    Cancer; 2016 Mar; 122(5):693-701. PubMed ID: 26717303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.
    Gulhati P; Raghav K; Shroff RT; Varadhachary GR; Kopetz S; Javle M; Qiao W; Wang H; Morris J; Wolff RA; Overman MJ
    Cancer; 2017 May; 123(6):1011-1017. PubMed ID: 27859010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases.
    Fishman PN; Pond GR; Moore MJ; Oza A; Burkes RL; Siu LL; Feld R; Gallinger S; Greig P; Knox JJ
    Am J Clin Oncol; 2006 Jun; 29(3):225-31. PubMed ID: 16755174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study.
    Koo DH; Yun SC; Hong YS; Ryu MH; Lee JL; Chang HM; Ryoo BY; Kang YK; Kim TW
    BMC Cancer; 2011 May; 11():205. PubMed ID: 21619586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.
    Overman MJ; Kopetz S; Lin E; Abbruzzese JL; Wolff RA
    Acta Oncol; 2010 May; 49(4):474-9. PubMed ID: 20397775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Strategies for Patients with Advanced Small Bowel Adenocarcinoma: Current Knowledge and Perspectives.
    Moati E; Overman MJ; Zaanan A
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
    Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
    Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Outcomes of Small Bowel Adenocarcinoma.
    Akce M; Jiang R; Zakka K; Wu C; Alese OB; Shaib WL; Behera M; El-Rayes BF
    Clin Colorectal Cancer; 2019 Dec; 18(4):257-268. PubMed ID: 31606297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.